Health Talks: Melanoma treatment research focuses on a flu vaccine

In this video, surgical oncologist Carlo Contreras, MD, explains new research being conducted at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James) to learn whether the flu vaccine can serve as a potential new way to treat melanoma. Researchers believe that the flu vaccine may help stimulate the immune system so it's better able to recognize and kill off melanoma cells.

The Pelotonia-funded research study is looking at the safety and side effects of the flu vaccine for patients who have both early and advanced stage melanoma. For patients with advanced melanoma, immunotherapy is the standard of care and it’s thought that using the flu vaccine in combination with immunotherapy treatment could improve its effectiveness.

Watch the full Health Talks video above to learn more about:

  • How the flu vaccine can be used to treat melanoma
  • How immunotherapy is used in melanoma treatment
  • Research findings and goals of the melanoma study
  • What’s next for melanoma research at Ohio State

At The James, there is no routine cancer

Our experts develop and deliver the most advanced targeted treatments leading to better outcomes and more hope.

Learn More


Related websites

Subscribe. The latest from Ohio State Health & Discovery delivered right to your inbox.


Get articles and stories about health, wellness, medicine, science and education delivered right to your inbox from the experts at Ohio State.

Required fields

Tell us more about yourself

By clicking "Subscribe" you agree to our Terms of Use.
Learn more about how we use your information by reading our Privacy Policy.